This document is not a NEPA document. It is an FDA notice of availability for a revised draft guidance entitled 'Addressing Misinformation About Medical Devices and Prescription Drugs: Questions and Answers,' published in the Federal Register on July 9, 2024. The guidance describes FDA's enforcement policy for firms voluntarily addressing internet-based third-party misinformation about approved/cleared medical products. It also includes a Paperwork Reduction Act notice soliciting public comment on associated information collection burdens. No NEPA environmental review is involved.